Charles Deignan Net Worth & Insider Trades

Charles Deignan - Chief Financial Officer, Clearside Biomedical, Inc

As of January 20, 2022

What is Charles Deignan's Net Worth?

The current estimated net worth of Clearside Biomedical, Inc's Chief Financial Officer, Charles Deignan, is estimated to be about $384.11K . Charles Deignan owns about 351,366 units of Clearside Biomedical, Inc common stock. In the last 6 years at Clearside Biomedical, Inc, Charles Deignan has sold an estimated value of $77.45K worth.

What is Charles Deignan's Past Insider Trading?

Charles Deignan's largest purchase order was 10,000 units , worth over $13.6K on March 18, 2019. Charles Deignan's largest sale order was 14,992 units , worth over $28.18K on June 3, 2020. In total, Charles Deignan has made about 18 transactions over 6 years of their time at Clearside Biomedical, Inc. Charles Deignan usually trades in June, with the busiest year in 2019. The most recent transaction was a sale order of 8,833 units , worth over $18.46K on January 20, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Charles Deignan's Salary in 2020?

As Chief Financial Officer of Clearside Biomedical, Inc, Charles Deignan has a total base salary of $342,876 . Charles Deignan received compensation valued at about $641,590 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of stock awards of $59,250 , option awards of $152,010 , other earnings, plans or compensations of $78,004 , and other compensation of $9,450 .

What is Charles Deignan's' Mailing Address?

  • Mailing address is C/o Clearside Biomedical, Inc. 1220 Old Alpharetta Road, Suite 300 Alpharetta GA 30005 GA

Clearside Biomedical, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
George Lasezkay 2020 $503,313 $286,513 $402,827 $163,577 $14,777 $1,371,007
George Lasezkay 2019 $371,235 $181,772 $299,915 $159,809 $32,461 $1,045,192
Charles A. Deignan 2020 $342,876 $59,250 $152,010 $78,004 $9,450 $641,590
Charles A. Deignan 2019 $332,890 $105,264 $107,753 $106,000 $9,300 $661,207
Thomas Ciulla 2020 $367,375 $59,250 $152,010 $83,578 $9,450 $671,663
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1539029/000119312521135345/d59948ddef14a.htm

What are Clearside Biomedical, Inc's Past Insider Trades?

Clearside Biomedical, Inc's most recent insider trade came on January 20, 2022 by Charles Deignan who sold 8,833 units worth $18.46K . In the last 6 years, insiders at Clearside Biomedical, Inc have sold an estimated value of $11.89M and bought an estimated value of $13.78M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Clay Thorp, Director,  Charles Deignan, Chief Financial Officer,  and George Lasezkay, CEO .

Clearside Biomedical, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1